罕见遗传变异与斯堪的纳维亚肌炎队列疾病易感性的关联
该研究对454例特发性炎性肌病(IIM)患者和1024名健康对照的约1900个免疫相关基因进行靶向DNA测序,通过基因聚合检验和罕见变异富集分析探索遗传变异与IIM易感性的关系,发现IFI35为潜在风险位点,提示I型干扰素通路激活的遗传特征,并在抗合成酶综合征亚组中检出AGER和PSMB8的聚合关联。
要点
- IFI35被鉴定为IIM的潜在遗传风险位点,提示I型干扰素通路激活的遗传特征。
- 抗合成酶综合征亚组中检出AGER和PSMB8的聚合遗传关联。
- IIM患者中同义和非编码罕见变异负荷增加,提示疾病易感性相关。
核心结论
- 罕见遗传变异对IIM及特定患者亚组的疾病易感性有贡献,并揭示了与既往基因表达谱一致的遗传关联。
研究设计与样本
- 靶向DNA测序挖掘约1900个免疫相关基因的编码及潜在调控单核苷酸变异,在454例IIM患者和1024名健康对照的斯堪的纳维亚病例对照队列中进行基因聚合检验及罕见变异和基因水平富集分析。
主要发现
- 所有变异(含罕见变异)的基因聚合检验将IFI35鉴定为IIM潜在遗传风险位点,提示I型干扰素通路激活的遗传特征。
- IFI35位点的功能注释突出显示与骨骼肌特异性基因PTGES3L相关的调控网络,作为IIM发病机制的潜在候选。
- 在抗合成酶综合征亚组中检出主要组织相容性复合体位点内AGER和PSMB8的聚合遗传关联,该亚组I型干扰素通路的遗传特征较不明显。
- 富集分析表明IIM患者中同义和非编码罕见变异负荷增加,提示这些类别的罕见变异与疾病易感性增加相关。
临床怎么用
- IFI35、AGER和PSMB8等遗传关联提示I型干扰素通路及抗原呈递相关基因在IIM易感性中的潜在作用,可供机制研究和亚组分类参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Idiopathic inflammatory myopathies (IIMs) are a heterogeneous group of complex autoimmune conditions characterized by inflammation in skeletal muscle and extramuscular compartments, and interferon (IFN) system activation. We undertook this study to examine the contribution of genetic variation to disease susceptibility and to identify novel avenues for research in IIMs. METHODS: Targeted DNA sequencing was used to mine coding and potentially regulatory single nucleotide variants from ~1,900 immune-related genes in a Scandinavian case-control cohort of 454 IIM patients and 1,024 healthy controls. Gene-based aggregate testing, together with rare variant- and gene-level enrichment analyses, was implemented to explore genotype-phenotype relations. RESULTS: Gene-based aggregate tests of all variants, including rare variants, identified IFI35 as a potential genetic risk locus for IIMs, suggesting a genetic signature of type I IFN pathway activation. Functional annotation of the IFI35 locus highlighted a regulatory network linked to the skeletal muscle-specific gene PTGES3L, as a potential candidate for IIM pathogenesis. Aggregate genetic associations with AGER and PSMB8 in the major histocompatibility complex locus were detected in the antisynthetase syndrome subgroup, which also showed a less marked genetic signature of the type I IFN pathway. Enrichment analyses indicated a burden of synonymous and noncoding rare variants in IIM patients, suggesting increased disease predisposition associated with these classes of rare variants. CONCLUSION: Our study suggests the contribution of rare genetic variation to disease susceptibility in IIM and specific patient subgroups, and pinpoints genetic associations consistent with previous findings by gene expression profiling. These features highlight genetic profiles that are potentially relevant to disease pathogenesis.
引用
- Bianchi M, Kozyrev SV, Notarnicola A, et al. Contribution of Rare Genetic Variation to Disease Susceptibility in a Large Scandinavian Myositis Cohort. Arthritis Rheumatol. 2021. PMID: 34279065. doi:10.1002/art.41929
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。